+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression



Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression



Journal of Acquired Immune Deficiency Syndromes 52(2): 203-208



The incidence of non-AIDS-defining malignancies (non-ADMs) is reported as unchanged or increasing in the highly active antiretroviral therapy era. Whether incidence of non-ADM is significantly higher in HIV-infected than in HIV-uninfected patients remains unclear. Incidence rates of malignancies were calculated in a cohort of veterans in care for HIV-infected and age, race, and gender-matched uninfected patients from 1997 to 2004. For HIV-infected patients, CD4 counts closest to first observation date were compared between those with and without cancer. Thirty three thousand four hundred twenty HIV-infected and 66,840 HIV-uninfected patients were followed for a median of 5.1 and 6.4 years. The incidence rate ratio of HIV infected to HIV uninfected was 1.6 (1260 vs. 841 per 100,000 person-years; 95% confidence interval: 1.5 to 1.7). Incidence rate ratio for individual cancers was highest for anal cancer (14.9; confidence interval: 10.1 to 22.1). Among HIV-infected patients, median CD4 counts were lower for those with non-ADM (249 vs. 270, P = 0.02), anal cancer (156 vs. 270; P < 0.001), and Hodgkin lymphoma (217 vs. 269; P = 0.03). Prostate cancer was associated with a higher CD4 count (311 vs. 266; P < 0.001). In the highly active antiretroviral therapy era, the incidence of non-ADMs is higher among HIV-infected than HIV-uninfected patients, adjusting for age, race, and gender. Some non-ADMs do not seem to be associated with significantly lower CD4 counts.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053791649

Download citation: RISBibTeXText

PMID: 19617846

DOI: 10.1097/qai.0b013e3181b033ab


Related references

Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: a systematic review. Journal of Infection and Public Health 8(1): 1-10, 2015

Non-AIDS-Defining Malignancies in Patients with HIV in the HAART Era. Current Infectious Disease Reports 12(1): 46-55, 2010

Use of statins and risk of AIDS-defining and non-AIDS-defining malignancies among HIV-1 infected patients on antiretroviral therapy. Aids 28(16): 2407-2415, 2014

Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002. Clinical Infectious Diseases 39(9): 1380-1384, 2004

Incidence and risk factors of non AIDS-defining as compared with AIDS-defining infections and cancers in a cohort of HIV-infected patients initiating a protease inhibitor -containing regimen. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 41: 320, 2001

Non-AIDS-defining malignancies and HAART. Aids Reader 17(9): 433-434, 2007

Non-aids defining malignancies in patients infected with HIV. Proceedings of the American Association for Cancer Research Annual Meeting (41): 759-760, 2000

Screening HIV-infected patients for non-AIDS-defining malignancies. Current Hiv/Aids Reports 6(2): 83-92, 2009

Characteristics of non-AIDS-defining malignancies in the HAART era: a clinico-epidemiological study. Journal of the International Aids Society 14: 16, 2011

Non-AIDS-defining hematological malignancies in HIV-infected patients: an epidemiological study in Japan. Aids 27(2): 279-283, 2013

Non-AIDS-defining malignancies among HIV-infected patients in the highly active antiretroviral therapy era. Current Hiv/Aids Reports 5(3): 140-149, 2008

Association of Viral Suppression With Lower AIDS-Defining and Non-AIDS-Defining Cancer Incidence in HIV-Infected Veterans: A Prospective Cohort Study. Annals of Internal Medicine 169(2): 87-96, 2018

Immunodeficiency as a risk factor for non-AIDS-defining malignancies in HIV-1-infected patients receiving combination antiretroviral therapy. Clinical Infectious Diseases 52(12): 1458-1465, 2011

Features of AIDS and AIDS defining diseases during the highly active antiretroviral therapy (HAART) era, compared with the pre-HAART period: a case-control study. Sexually Transmitted Infections 76(2): 145-B-146, 2000

Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of Northern Italy, 1999-2009. HIV Medicine 14(8): 481-490, 2014